Correction to: identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study

@inproceedings{Yang2017CorrectionTI,
  title={Correction to: identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study},
  author={Hanbo Yang and Qinglin Peng and Liguo Yin and Shanshan Li and Jingli Shi and Ya-mei Zhang and Xin Lu and Xiaoming Shu and Sigong Zhang and Guochun Wang},
  booktitle={Arthritis research & therapy},
  year={2017}
}
BACKGROUND Cancer is a significant complication contributing to increased mortality in idiopathic inflammatory myopathies (IIMs), and the association between IIMs and cancer has been extensively reported. Myositis-specific autoantibodies (MSAs) can help to stratify patients into more homogeneous groups and may be used as a biomarker for cancer-associated myositis. In this study, we aimed to systematically define the cancer-associated MSAs in IIMs. METHODS Serum from 627 patients with IIMs was… CONTINUE READING